Skip to main content

Table 1 Clinical profile of the study population

From: Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study

Patient clinical characteristics

Normal pregnancy

Preeclamptic pregnancy

n

21

15

Age (years)

26.3 ± 5.9

23.7 ± 4.5

Body Mass Index (BMI) (kg/m2)

29.8 ± 6.3

29.6 ± 4.6

Birth weight (grams)

3035.4 ± 535.0

2599 ± 697.3a

Gestational age(weeks)

37.8 ± 2.1

s36.6 ± 2.4

Systolic blood pressure (mm Hg)

135 ± 13

174 ± 15b

Diastolic blood pressure (mm Hg)

77 ± 9

110 ± 7b

Mean blood pressure (mm Hg)

96 ± 9

131 ± 8b

Proteinuria (0-4+)

none

>1+

Number of patients receiving anti-hypertensive medications

none

5

  1. Values are expressed as mean ± SD. ap < 0.05, bp < 0.0001 versus normal pregnancy
  2. ‡Anti-hypertensive treatment for five preeclamptic patients included Hydralazine and Labetalol.